why choose us

First received: January 05, 2023

Clinical Trial: A First-in-Human, Phase 1 Study of TST003 in Subjects With Solid Tumors

Study Status: Completed

Recruit Status: RECRUITING

Condition: Locally Advanced Solid Tumor

Study Type: INTERVENTIONAL


Official Title: A First-in-Human, Open-Label, Multi-Center Phase 1 Study of TST003 in Subjects With Locally Advanced or Metastatic Solid Tumors

Brief Summary: The goal of this clinical trial is to test the safety of TST003 in patients with cancer.The main question[s] it aims to answer are:What is the recommended dose patients can safely receive?How long does this drug remain in the body after administration?What are the side effects of this drug?Does your cancer respond to TST003?Participants on this study will get TST003 intravenously (through a needle into your vein), once every 3 weeks.You may need to come to the study site 2-4 times to have tests to see if you are…

Read more